Results 261 to 270 of about 164,300 (382)

EndoCompass Project: Endocrine Laboratory Medicine.

Horm Res Paediatr
Heijboer AC, Hillebrand JJ, Keevil B, Ladang A, Davies E, Mertens J, Ozben T, Stankovic S, van Herwaarden AE, Raverot V.   +9 more
europepmc   +1 more source

Adrenal Insufficiency During Treatment With Immune‐Checkpoint Inhibitors: How to Simplify the Diagnostic Pathway?

Clinical Endocrinology, Volume 104, Issue 1, Page 39-46, January 2026.
ABSTRACT Objective and Background Early identification of adrenal insufficiency (AI) during immune‐checkpoint inhibitors (ICIs) is crucial to prevent life‐threatening consequences; however, the diagnosis is challenging. Design, Patients and Measurement In this prospective observational study, ICI‐treated cancer patients with morning serum cortisol (SC)
Alice Nervo, Giovanni Gruosso, Marta Marino, Enrica Migliore, Matteo Rubiolo, Elisa Vaccaro, Emanuela Arvat   +6 more
wiley   +1 more source

Alcohol exposure significantly influences gene expression in the hypothalamus, highlighting complex links with gonadotropin-releasing hormone signaling and thyroid hormone production in adolescent mice. [PDF]

BMC Med Genomics
Sun G, Peng Y, Hu C, Zheng Y, Cheng Y, Qi X, Jin Y.   +6 more
europepmc   +1 more source

Unliganded Thyroid Hormone Receptor α Can Target TATA-Binding Protein for Transcriptional Repression

, 1996
Joseph D. Fondell, Franck Brunel, Koji Hisatake, Robert G. Roeder   +3 more
openalex   +2 more sources

Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double‐blind, placebo‐controlled, phase 3 trial (SYNCHRONIZE™‐1)

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 337-346, January 2026.
Abstract Aims Survodutide, a novel glucagon receptor and glucagon‐like peptide‐1 (GLP‐1) receptor dual agonist, elicited significant weight loss in a phase 2 trial in individuals with obesity without type 2 diabetes (T2D). Two multinational phase 3 trials are investigating survodutide for obesity management in individuals with or without T2D. We report
Carel W. le Roux, Sean Wharton, Biykem Bozkurt, Elke Platz, Gabriele Bleckert, Samina Ajaz Hussain, Martina Brueckmann, Elena Startseva, Isabel M. Kloer, Lee M. Kaplan   +9 more
wiley   +1 more source

National recommendations of the Croatian society of medical biochemistry and laboratory medicine: Thyroid function tests from the laboratory point of view. [PDF]

Biochem Med (Zagreb)
Bokulić A, Zec I, Marijančević D, Siter Kuprešanin M, Goreta S, Đuras A, Đurić K, Jelisavac Ćosić S, Lukić I, Serdar Hiršl T, Stanišić L, Šupe-Domić D, Pezo A, Kocijančić M.   +13 more
europepmc   +1 more source

Competitive Binding of Persistent Organic Pollutants to the Thyroid Hormone Transport Protein Transthyretin in Glaucous Gull (Larus hyperboreus).

, 2015
Åse-Karen Mortensen
openalex   +1 more source

Magnetic resonance imaging features of hypophysitis in patients with cancer treated with immune checkpoint inhibitors

Journal of Neuroendocrinology, Volume 38, Issue 1, January 2026.
This study evaluated pituitary MRI results in cancer patients who experienced immune‐related hypophysitis while receiving immune checkpoint inhibitor treatment. MRI abnormalities were present in 63% of patients at follow‐up and 56% of patients at diagnosis, mostly in patients with multiple hormonal deficiencies.
Anna Angelousi, Stavroula Asimakopoulou, Charis Bourgioti, Amalia Anastasopoulou, Spyridon Kazanas, Panagiotis Diamantopoulos, Athina Karabela, Elisavet Tasouli, Lia‐Angela Moulopoulos, Dimitrios C. Ziogas, Helen Gogas   +10 more
wiley   +1 more source

Thyroid Response to Peripheral Endocrine Factors: Neuropeptide Y Influences Thyroid Function in the Reptile <i>Podarcis siculus</i>. [PDF]

Int J Mol Sci
Sciarrillo R, Lallo A, Carrella F, Gallicchio V, Mileo A, Valvano BS, De Falco M.   +6 more
europepmc   +1 more source

Impulse Dyscontrol Symptoms Are Related to Amyloid Beta in Patients With Subjective Cognitive Decline and Mild Cognitive Impairment

Psychogeriatrics, Volume 26, Issue 1, January 2026.
ABSTRACT Introduction The relationship between neuropsychiatric symptoms (NPSs) and Alzheimer's disease (AD) pathophysiology, considering cerebrospinal fluid (CSF) biomarkers, is still not clarified and the available results in the literature are contradictory especially when it comes to the prodromic stages of AD.
Ana Luiza Gonçalves Rochetti, Isadora Cristina Ribeiro, Lucas Luchesi Barnes, Liara Rizzi, Italo Karmann Aventurato, Brenda Costa Gonçalves, Marjorie Cristina Rocha da Silva, Marcio Luiz Figueredo Balthazar   +7 more
wiley   +1 more source